FILIDITY Trademark

Trademark Overview

On Wednesday, June 14, 2017, a trademark application was filed for FILIDITY with the United States Patent and Trademark Office. The USPTO has given the FILIDITY trademark a serial number of 87489027. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 25, 2021. This trademark is owned by FILIDITY. The FILIDITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
filidity

General Information

Serial Number87489027
Word MarkFILIDITY
Filing DateWednesday, June 14, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 25, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 24, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 21, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NameFILIDITY
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, January 25, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 25, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 8, 2020EXTENSION 5 GRANTED
Wednesday, June 3, 2020EXTENSION 5 FILED
Wednesday, June 3, 2020TEAS EXTENSION RECEIVED
Wednesday, December 11, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 9, 2019EXTENSION 4 GRANTED
Monday, December 9, 2019EXTENSION 4 FILED
Monday, December 9, 2019TEAS EXTENSION RECEIVED
Wednesday, November 27, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 27, 2019ASSIGNED TO LIE
Monday, November 25, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2019EXTENSION 3 GRANTED
Monday, June 3, 2019EXTENSION 3 FILED
Monday, June 3, 2019TEAS EXTENSION RECEIVED
Thursday, November 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 27, 2018EXTENSION 2 GRANTED
Tuesday, November 27, 2018EXTENSION 2 FILED
Tuesday, November 27, 2018TEAS EXTENSION RECEIVED
Saturday, September 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 21, 2018EXTENSION 1 GRANTED
Thursday, May 24, 2018EXTENSION 1 FILED
Friday, September 14, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 6, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 17, 2018ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
Friday, June 1, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 24, 2018TEAS EXTENSION RECEIVED
Tuesday, December 19, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 14, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 13, 2017ASSIGNED TO EXAMINER
Wednesday, June 21, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, June 17, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

filidity preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases